The landscape of vestibular medicine is undergoing a significant shift as clinicians and researchers move away from viewing balance disorders as isolated incidents toward a more integrated understanding of comorbidity. This evolution was the primary focus of a pivotal session at the Vestibular Disorders Association’s (VeDA) Life Rebalanced Live virtual conference. Titled “When Conditions Overlap: PPPD, Vestibular Migraine, and Other Comorbidities,” the session featured prominent neurologists Dr. Shin Beh and Dr. Kristen Steenerson, alongside patient advocates Kayla McCain and Judi Rosenthal. The discussion illuminated the complex reality for millions of patients who find that their dizziness is not the result of a single malfunction, but rather a sophisticated interplay of neurological, physiological, and psychological factors.
The Diagnostic Landscape: Beyond Single-Condition Models
For decades, the clinical approach to vestibular disorders often sought a singular "smoking gun"—a specific inner ear infection or a mechanical issue like loose calcium crystals. However, modern neuro-otology increasingly recognizes that vestibular disorders are rarely simple. The conference highlighted that Persistent Postural-Perceptual Dizziness (PPPD) and Vestibular Migraine (VM) are frequently comorbid, creating a "perfect storm" of symptoms that can be difficult to untangle without specialized expertise.
Vestibular Migraine is now recognized as one of the leading causes of episodic vertigo, characterized by bouts of dizziness that may or may not be accompanied by a headache. Patients often report sensitivities to light (photophobia), sound (phonophobia), and motion. Conversely, PPPD is defined by a more constant state of perceived motion or unsteadiness. According to the diagnostic criteria established by the World Health Organization and the Bárány Society, PPPD is a chronic functional vestibular disorder that typically follows an acute event, such as a bout of Benign Paroxysmal Positional Vertigo (BPPV) or a period of intense stress.
The intersection of these conditions is not coincidental. Research discussed during the session suggests that the neurological pathways involved in migraine—specifically those governing sensory processing—are the same pathways that become dysregulated in PPPD. When these systems are hyper-sensitized, the brain loses its ability to filter out "background noise" from the balance organs, leading to a state of chronic dizziness.
Biological Vulnerabilities: Genetics, Hormones, and the Brain
A significant portion of the session was dedicated to the biological underpinnings that predispose certain individuals to overlapping vestibular conditions. Dr. Beh and Dr. Steenerson noted that many patients exhibit early signs of sensory processing sensitivity long before their first vertigo attack. A history of childhood motion sickness, for instance, is a strong clinical indicator of a "migrainous brain" that may later manifest as vestibular migraine or PPPD.
Hormonal fluctuations emerged as a critical factor in the prevalence and severity of these disorders. Statistics indicate that vestibular disorders disproportionately affect women, particularly during perimenopause and menopause. Estrogen and progesterone are neuroactive steroids that influence neurotransmitter systems, including serotonin and dopamine, which are central to both mood and sensory regulation. When hormonal levels fluctuate, the "vestibular threshold" drops, making the individual more susceptible to triggers that they might have previously tolerated.
Furthermore, the role of neurotransmitters cannot be overstated. Serotonin and dopamine are essential for the smooth functioning of the brain’s "gain control" system. In patients with comorbid VM and PPPD, this control system is often poorly calibrated, leading to an exaggerated response to visual stimuli, such as moving crowds, scrolling on a computer screen, or walking down the aisles of a grocery store.
The Threshold Model: Understanding Stress and Resilience
One of the most impactful frameworks discussed during the conference was the "Threshold Model" of vestibular dysfunction. Experts clarified a common misconception: while stress and anxiety are frequently present in vestibular patients, they are generally not the primary cause of the disorder. Instead, stress acts as an amplifier or a trigger that pushes a vulnerable system over its limit.
Every individual has a physiological threshold for sensory input and stress. Factors such as poor sleep hygiene, dehydration, hormonal shifts, and existing vestibular damage lower this threshold. When a patient is under significant emotional or physical stress, the nervous system becomes overloaded, resulting in an "overflow" of symptoms. This explains why a patient might feel relatively stable one day but experience a total relapse the next after a night of poor sleep or a stressful work meeting.
By understanding this model, treatment can shift from "curing" a single cause to "raising the threshold." This involves a comprehensive approach to stabilizing the nervous system through various lifestyle and medical interventions, thereby increasing the patient’s resilience to unavoidable daily stressors.
Multidisciplinary Treatment Strategies
Because overlapping conditions affect multiple systems—the inner ear, the brain, and the autonomic nervous system—the consensus among the panelists was that a multifaceted treatment plan is essential. The "magic bullet" approach is rarely successful in complex cases of comorbidity.
- Managing Episodic Triggers: The first priority is often to stabilize episodic conditions like Vestibular Migraine or BPPV. If a patient is having frequent, unpredictable migraine attacks, the brain remains in a state of high alert, making it nearly impossible to treat the underlying PPPD. This may involve preventive medications such as beta-blockers, anticonvulsants, or antidepressants that stabilize neurotransmitter levels.
- Vestibular Rehabilitation Therapy (VRT): Once episodic triggers are managed, VRT is used to "retrain" the brain. This specialized form of physical therapy uses habituation exercises to desensitize the patient to motion and visual triggers.
- Cognitive Behavioral Therapy (CBT): For many, the chronic nature of dizziness leads to secondary anxiety and "fear of falling." CBT is a clinical tool used to break the cycle of "vigilance-anxiety-dizziness," helping patients reduce the autonomic nervous system’s hyper-reactive response to vestibular sensations.
- Pharmacological Support: In addition to migraine preventatives, SSRIs and SNRIs are often utilized not just for mood, but for their ability to regulate the sensory processing centers of the brain, which is crucial for treating the "functional" aspects of PPPD.
Lifestyle as Medicine: Diet and Sleep
The role of lifestyle in managing complex vestibular conditions was a recurring theme. The panelists emphasized that the "migraine brain" thrives on routine. Irregular sleep patterns are among the most potent triggers for vestibular episodes. Maintaining a consistent sleep-wake cycle, even on weekends, can significantly stabilize the nervous system.
Dietary choices also play a supportive role. While the "migraine diet" has historically been very restrictive—eliminating everything from aged cheese to chocolate—the experts at the conference suggested a more balanced approach. The Mediterranean diet, rich in anti-inflammatory fats, whole grains, and lean proteins, is increasingly recommended for its neuroprotective benefits. Hydration is equally critical; even mild dehydration can alter the fluid balance in the inner ear and trigger a spike in symptoms.
Patient Perspectives: The Reality of the Journey
The inclusion of patient panelists Kayla McCain and Judi Rosenthal provided a necessary human element to the clinical discussion. Their stories highlighted the often-lengthy chronology of diagnosis. Rosenthal described a decades-long struggle with symptoms that began in childhood, involving a complex web of autoimmune and gastrointestinal issues that complicated her vestibular health. Her experience underscored the "invisible" nature of these conditions and the profound disorientation that occurs when the brain and the balance system are out of sync.
McCain’s story illustrated the "evolution" of vestibular disorders. What began as episodic vestibular migraine in her twenties eventually morphed into PPPD after a period of intense symptoms. She described the specific sensation of "visual bouncing" and dissociation, symptoms that are frequently misunderstood by general practitioners but are hallmark signs of PPPD to a vestibular specialist. Both patients emphasized that receiving a name for their overlapping conditions was a turning point, allowing them to stop searching for a "cure" for a single ailment and start managing a complex system.
Future Directions and Clinical Innovations
The session concluded with an optimistic look at the future of vestibular medicine. Research is currently expanding into the role of CGRP (calcitonin gene-related peptide) inhibitors—a newer class of drugs originally designed for classic migraines—to see how they might specifically benefit those with vestibular symptoms.
Additionally, neuromodulation devices, which use electrical or magnetic pulses to calm overactive nerve pathways, are showing promise in clinical trials. These non-invasive technologies could offer an alternative for patients who do not tolerate traditional medications.
The overarching message of the conference was one of integration. As the medical community continues to map the overlapping pathways of the brain and the vestibular system, the hope is for faster diagnoses and more personalized care. For the millions living with the dizzying reality of overlapping conditions, the shift toward a "whole-person" approach represents a significant step toward reclaiming a life of balance.